Back to search

Netherlands· NL-aab7ddbe6163

Edoxaban Reddy 15 mg filmomhulde tabletten

A edoxaban product containing edoxabantosilaat 1-water, registered in Netherlands by Reddy Holding GmbH. The same ATC class is registered in 17 of our 19 countries.

ATC B01AF03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEdoxaban Reddy 15 mg filmomhulde tabl…ATCB01AF03REGISTER NO.NL-aab7ddbe6163PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Edoxaban is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AF03 (edoxaban), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Edoxaban · ATC B01AF03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of edoxaban costs, country by country.

Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Edoxaban · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • IT Italy$7.87
  • CH Switzerland$6.81
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
EDOXABANTOSILAAT 1-WATER
Manufacturer
Reddy Holding GmbH
Country
Netherlands (NL)
ATC code
B01AF03
ATC class
Edoxaban
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    133412

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

262 interactions on record for edoxaban.

Graded by severity as the source publishes them — 182 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Edoxaban · interactions on record

262 records

  • 182 severe
  • 80 moderate

Most severe, free to view

  • RolapitantA04AD14severe
  • EliglustatA16AX10severe
  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Edoxaban in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All edoxaban products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Edoflusio, Edoxaban !@ctavis
  • Belgium · Edoxaban Hcs, Edoxaban Sandoz
  • Bulgaria · Edoflusio, Делианда
  • Czechia · Delianda, Edoxaban +pharma
  • Germany · Edoxaban 1 A Pharma, Edoxaban 123 Acurae Pharma
  • Denmark · Arelzamio, Dijuga
  • Estonia · Delianda, Edoflusio
  • Spain · Edoxabán Almus, Edoxabán Cinfa
  • Finland · Edoxaban Avansor, Edoxaban Krka
  • France · Oblonela
  • United Kingdom (Northern Ireland) · Edoxaban, Edoxaban Accord
  • Greece · Delianda, Edoxaban Pharmapath
  • Croatia · Cagluen, Delianda
  • Hungary · Cagluen, Delianda
  • Ireland · Edoxaban Accord, Edoxaban Krka
  • Iceland · Edoxaban Accord, Edoxaban Krka
  • Italy · Edoxaban Dr. Reddy’s, Edoxaban Hcs
  • Liechtenstein · Lixiana, Roteas
  • Lithuania · Delianda, Edoflusio
  • Luxembourg · Oblonela
  • Latvia · Delianda, Edoflusio
  • Malta · Arelzamio, Dijuga
  • Norway · Edoxaban Krka, Edoxaban Sandoz
  • Poland · Delianda, Edoflusio
  • Portugal · Edoxabano Bluepharma, Edoxabano Kern Pharma
  • Romania · Cagluen, Delianda
  • Sweden · Edoflusio, Edoxaban Avansor
  • Slovenia · Delianda, Edoflusio
  • Slovakia · Delianda, Edoxaban Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce58c0f3-31c6-4ff9-81bf-08196986f9d3
GET /v1/drugs/ce58c0f3-31c6-4ff9-81bf-08196986f9d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h133412_smpc.pdf",
  "strength": null,
  "atc_label": "Edoxaban",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133412",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CROSPOVIDON (E 1202)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)"
  ],
  "substances": [
    "EDOXABANTOSILAAT 1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133412.pdf",
  "authorised_at": "2025/06/11",
  "procedure_number": "SE/H/2554/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "133412",
  "additional_monitoring": "N"
}

See everything about edoxaban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.